Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihyd ro-2(1H)-indol-2-one (=ziprasidone), its preparation and its use as dopamine D2 antagonist

US Patent 6245765 · Granted Jun 12, 2001

Estimated economic value: $481,578,000

Assignee

Inventors

View full patent text on Google Patents →